Literature DB >> 22158490

Dosimetric and clinical predictors of radiation-induced lung toxicity in esophageal carcinoma.

Shu-Chai Zhu1, Wen-Bin Shen, Zhi-Kun Liu, Juan Li, Jing-Wei Su, Yu-Xiang Wang.   

Abstract

AIMS AND
BACKGROUND: Radiation-induced lung toxicity occurs frequently in patients with esophageal carcinoma. This study aims to evaluate the clinical and three-dimensional dosimetric parameters associated with lung toxicity after radiotherapy for esophageal carcinoma. METHODS AND STUDY
DESIGN: The records of 56 patients treated for esophageal carcinoma were reviewed. The Radiation Therapy Oncology Group criteria for grading of lung toxicity were followed. Spearman's correlation test, the chi-square test and logistic regression analyses were used for statistical analysis.
RESULTS: Ten of the 56 patients developed acute toxicity. The toxicity grades were grade 2 in 7 patients and grade 3 in 3 patients; none of the patients developed grade 4 or worse toxicity. One case of toxicity occurred during radiotherapy and 9 occurred 2 weeks to 3 months after radiotherapy. The median time was 2.0 months after radiotherapy. Fourteen patients developed late irradiated lung injury, 3 after 3.5 months, 7 after 9 months, and 4 after 14 months. Radiographic imaging demonstrated patchy consolidation (n = 5), atelectasis with parenchymal distortion (n = 6), and solid consolidation (n = 3). For acute toxicity, the irradiated esophageal volume, number of fields, and most dosimetric parameters were predictive. For late toxicity, chemotherapy combined with radiotherapy and other dosimetric parameters were predictive. No obvious association between the occurrence of acute and late injury was observed.
CONCLUSIONS: The percent of lung tissue receiving at least 25 Gy (V25), the number of fields, and the irradiated length of the esophagus can be used as predictors of the risk of acute toxicity. Lungs V30, as well as chemotherapy combined with radiotherapy, are predictive of late lung injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158490     DOI: 10.1177/030089161109700510

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  7 in total

1.  Postoperative complications do not affect long-term outcome in esophageal cancer patients.

Authors:  Kirsten Lindner; Mathias Fritz; Christina Haane; Norbert Senninger; Daniel Palmes; Richard Hummel
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

2.  Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.

Authors:  Guillaume Peyraga; Delphine Caron; Thibaut Lizee; Yann Metayer; Anne-Lise Septans; Yoann Pointreau; Fabrice Denis; Gerard Ganem; Cedrik Lafond; Sophie Roche; Olivier Dupuis
Journal:  Support Care Cancer       Date:  2017-12-23       Impact factor: 3.603

3.  Histone deacetylase 6-mediated downregulation of TMEM100 expedites the development and progression of non-small cell lung cancer.

Authors:  Yanyun Wang; Minwen Ha; Man Li; Lin Zhang; Yitong Chen
Journal:  Hum Cell       Date:  2021-10-23       Impact factor: 4.174

4.  Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer.

Authors:  Yaqin Zhao; Lu Chen; Shu Zhang; Qiang Wu; Xiaoqin Jiang; Hong Zhu; Jin Wang; Zhiping Li; Yong Xu; Ying Jie Zhang; Sen Bai; Feng Xu
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

5.  Investigation of Predictors to Achieve Acceptable Lung Dose in T-Shaped Upper and Middle Esophageal Cancer With IMRT and VMAT.

Authors:  Yan Shao; Hua Chen; Hao Wang; Yanhua Duan; Aihui Feng; Ying Huang; Hengle Gu; Qing Kong; Zhiyong Xu
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

6.  Dose-volume analysis for respiratory toxicity in intrathoracic esophageal cancer patients treated with definitive chemoradiotherapy using extended fields.

Authors:  Satoshi Tanabe; Miyako Myojin; Shinichi Shimizu; Masaharu Fujino; Hiroaki Takahashi; Hiroki Shirato; Yoichi M Ito; Masayori Ishikawa; Masao Hosokawa
Journal:  J Radiat Res       Date:  2013-05-09       Impact factor: 2.724

7.  Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.

Authors:  X Pu; L Wang; J Y Chang; M A T Hildebrandt; Y Ye; C Lu; H D Skinner; N Niu; G D Jenkins; R Komaki; J D Minna; J A Roth; R M Weinshilboum; X Wu
Journal:  Clin Pharmacol Ther       Date:  2014-07-23       Impact factor: 6.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.